Xinyu (Quanzhou Fengze) Cross-border E-commerce Co., Ltd. – Trademark Portfolio

Entity Type: 99

Xinyu (Quanzhou Fengze) Cross-border E-commerce Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include EMPERXNATION. The owner is based in Quanzhou,Fujian.

2203, Bldg 20, Vanke City Light Phase II

Quanzhou,Fujian 362000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Xinyu (Quanzhou Fengze) Cross-border E-commerce Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Xinyu (Quanzhou Fengze) Cross-border E-commerce Co., Ltd. have?

Xinyu (Quanzhou Fengze) Cross-border E-commerce Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Xinyu (Quanzhou Fengze) Cross-border E-commerce Co., Ltd. file in?

Xinyu (Quanzhou Fengze) Cross-border E-commerce Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are Xinyu (Quanzhou Fengze) Cross-border E-commerce Co., Ltd.'s most well-known trademarks?

Xinyu (Quanzhou Fengze) Cross-border E-commerce Co., Ltd.'s registered trademark portfolio includes well-known marks such as EMPERXNATION. These are among 1 currently registered trademark in the portfolio.

What is Xinyu (Quanzhou Fengze) Cross-border E-commerce Co., Ltd.'s trademark registration success rate?

Xinyu (Quanzhou Fengze) Cross-border E-commerce Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.